What are the top competitors of MLMIB.PA in Healthcare sector?

The top competitors of MLMIB.PA in the Healthcare sector are: Uniphar plc (UPR.IR), Bastide Le Confort Médical SA (BLC.PA).

Which has better valuations & earnings, MLMIB.PA or its competitors?

MLMIB.PA has a market cap of 790.3K and a Dividend Yield of N/A compared to its competitors.

Which stock is more profitable: MLMIB.PA or its competitors?

MLMIB.PA has an EPS of €-0.01, while UPR.IR has an EPS of €0.24. So, MLMIB.PA is more profitable compared to UPR.IR.

What is MLMIB.PA stock volatility and risk in terms of investment?

MLMIB.PA has daily volatility of 0% as compared to its competitor UPR.IR which is 3.33%. MLMIB.PA is less volatile as compared to competitors and has low risk.

Is MLMIB.PA stock profitable?

MLMIB.PA has a Return on Equity (ROE) of -0.00%. So, MLMIB.PA is more profitable.

What is MLMIB.PA stock’s 52 weeks high and low?

MLMIB.PA stock has a 52-week high of (€0.117) and a low of (€0.032).

What was the average volume of MLMIB.PA stock?

The average volume of MLMIB.PA is (-) in terms of investment.

Metrics in Balance N.V. (MLMIB.PA) Competitors

Metrics in Balance N.V. MLMIB.PA Peers

See (MLMIB.PA) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Distribution Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
MLMIB.PA	€0.03	N/A	790.3K	-3.30	-€0.01	N/A
UPR.IR	€3.66	+2.38%	948.7M	15.23	€0.24	+0.53%
BLC.PA	€27.70	N/A	202.4M	23.88	€1.16	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MLMIB.PA vs UPR.IR Comparison

MLMIB.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLMIB.PA stands at 790.3K. In comparison, UPR.IR has a market cap of 948.7M. Regarding current trading prices, MLMIB.PA is priced at €0.03, while UPR.IR trades at €3.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLMIB.PA currently has a P/E ratio of -3.30, whereas UPR.IR's P/E ratio is 15.23. In terms of profitability, MLMIB.PA's ROE is -0.00%, compared to UPR.IR's ROE of +0.08%. Regarding short-term risk, MLMIB.PA is less volatile compared to UPR.IR. This indicates potentially lower risk in terms of short-term price fluctuations for MLMIB.PA.

Metrics in Balance N.V.